Edwards Lifesciences Corp. (EW)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Michael A. Mussallem
Employees:
15,700
ONE EDWARDS WAY, IRVINE, CA 92614
9492502500

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.

Data derived from most recent annual or quarterly report
Market Cap 49.931 Billion Shares Outstanding618.26 Million Avg 30-day Volume 4.063 Million
P/E Ratio30.6009 Dividend Yield0.0 EPS2.46
Price to Revenue8.6526 Debt to Equity0.1147 EBITDA1.891 Billion
Price to Book Value8.0203 Operating Margin32.4855 Enterprise Value44.783 Billion
Current Ratio3.028 EPS Growth0.025 Quick Ratio1.873
1 Yr BETA 0.9361 52-week High/Low 131.1 / 67.13 Profit Margin28.2755
Operating Cash Flow Growth-29.6692 Altman Z-Score14.1684 Free Cash Flow to Firm 687.125 Million
Earnings Report2023-04-26
View SEC Filings from EW instead.

View recent insider trading info

Funds Holding EW (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EW

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-02-21:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-04:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    77.9 Thousand total shares from 11 transactions

    Exercise Derivative Conversion (M)

    96.9 Thousand total shares from 8 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CHOPRA DAVEEN CVP, TMTT

    • Officer
    18,911 2023-03-15 11

    BOBO DONALD E JR CVP,STRATEGY/CORP DEVELOPMENT

    • Officer
    218,195 2023-03-08 14

    LEMERCIER JEAN-LUC M CVP, EMEACLA AND JAPAC

    • Officer
    168,875 2023-03-08 6

    ULLEM SCOTT B. CVP, CHIEF FINANCIAL OFFICER

    • Officer
    275,606 2023-02-21 6

    STONE HEISZ LESLIE

    • Director
    27,480 2023-02-16 2

    WOOD LARRY L CVP & GRP PRESIDENT TAVR & SSH

    • Officer
    205,963 2023-02-16 12

    MUSSALLEM MICHAEL A CHAIRMAN & CEO

    • Officer
    • Director
    7,679,929 2023-02-15 13

    SZYMAN CATHERINE M. CVP, CRITICAL CARE

    • Officer
    27,699 2022-12-31 6

    ZOVIGHIAN BERNARD J CVP, TMTT

    • Officer
    21,247 2022-08-05 9

    WANG HUIMIN CVP, JAPAN & INTERCONTINENTAL

    • Officer
    125,106 2022-07-08 6

    SELLERS ROBERT W.A. SVP, CORPORATE CONTROLLER

    • Officer
    31,845 2022-05-17 3

    LAVIOLETTE PAUL A

    • Director
    4,915 2022-05-04 1

    LORANGER STEVEN R

    • Director
    67,617 2022-05-04 1

    VALERIANI NICHOLAS J

    • Director
    66,111 2022-05-04 1

    GALLAHUE KIERAN

    • Director
    63,221 2022-05-04 1

    MARSH MARTHA H.

    • Director
    29,077 2022-05-04 2

    SEQUEIRA RAMONA

    • Director
    8,218 2022-05-04 1

    LINK WILLIAM J PHD

    • Director
    22,121 2020-05-08 0

    VON SCHACK WESLEY W

    • Director
    39,480 2019-08-01 0

    VERGUET PATRICK B CVP, EUROPE

    • Officer
    129,137 2017-05-31 0

    CARDIS JOHN T

    • Director
    93,399 2016-08-10 0

    MCNEIL BARBARA J

    • Director
    101,126 2016-02-04 0

    INGRAM ROBERT ALEXANDER

    • Director
    32,367 2015-05-15 0

    BOWLIN MICHAEL R

    • Director
    81,751 2014-11-14 0

    SOLOMON CARLYN D CVP, CRITICAL CARE & VASCULAR

    • Officer
    31,154 2014-10-28 0

    PYOTT DAVID E I

    • Director
    53,582 2014-05-09 0

    ABATE THOMAS M CVP, CFO

    • Officer
    0 2013-05-14 0

    GARREN BRUCE P CVP, PUBLIC AFFAIRS/SPECIAL CO

    • Officer
    No longer subject to file 2013-05-13 0

    REDMOND PAUL C CVP, GLOBAL OPERATIONS

    • Officer
    No longer subject to file 2013-05-13 0

    MCCAULEY CHRISTINE Z CVP, HUMAN RESOURCES

    • Officer
    No longer subject to file 2013-05-13 0

    KEHL JOHN H JR CVP, STRATEGY & CORP DEV

    • Officer
    101,767 2013-05-07 0

    REINDL ROBERT C CVP, H.R. AND COMMUNICATIONS

    • Officer
    1,124 2012-07-27 0

    WEISNER AIMEE S CVP, GENERAL COUNSEL

    • Officer
    0 2012-05-09 0

    NEVINNY CORINNE H CVP & PRES., GLOBAL OPS

    • Officer
    0 2010-05-13 0

    NEAL PHILIP M

    • Director
    27,333 2008-08-12 0

    LOUCKS VERNON R JR

    • Director
    24,133 2008-05-09 0

    BESSLER ANITA CVP

    • Officer
    34,724 2007-08-31 0

    FOSTER STUART L CVP, CRITICAL CARE / VASCULAR

    • Officer
    79,604 2007-05-10 0

    MARTIN JOHN ALEXANDER CVP, NORTH AMERICA

    • Officer
    44,300 2007-05-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-03-15 17:28:08 -0400 2023-03-15 M 4,435 d 0 direct

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-03-15 17:28:08 -0400 2023-03-15 S 4,435 $77.47 d 18,911 direct yes -1.4284 -2.8812 0.0 1 -3.0521 5

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-03-15 17:28:08 -0400 2023-03-15 M 4,435 $45.28 a 23,346 direct yes -1.4284 -2.8812 0.0 1 -3.0521 5

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-03-14 M 29,375 d 58,750 direct

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-03-14 M 29,375 $35.20 a 90,323 direct yes 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-03-14 S 10,700 $77.86 d 60,948 direct yes 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-03-14 G 9,500 d 71,648 direct 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO by living trust

    2023-03-14 20:47:24 -0400 2023-03-14 G 9,500 a 3,597,922 indirect 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-03-14 S 9,175 $77.32 d 81,148 direct yes 3.0574 -0.0881 3.0574 2 -0.0881 6

    LEMERCIER JEAN-LUC M - Officer CVP, EMEACLA AND JAPAC

    2023-03-08 17:57:04 -0500 2023-03-08 S 50 $77.43 d 175,465 direct yes -2.2228 7.7338 7.7338 6 -2.2228 2

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-03-08 17:56:04 -0500 2023-03-08 M 6,725 d 6,725 direct

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-03-08 17:56:04 -0500 2023-03-08 S 6,725 $76.96 d 62,561 direct yes -2.2228 7.7338 7.7338 6 -2.2228 2

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-03-08 17:56:04 -0500 2023-03-08 M 6,725 $35.20 a 69,286 direct yes -2.2228 7.7338 7.7338 6 -2.2228 2

    LEMERCIER JEAN-LUC M - Officer CVP, EMEACLA AND JAPAC

    2023-03-08 17:57:04 -0500 2023-03-08 M 6,640 d 13,280 direct

    LEMERCIER JEAN-LUC M - Officer CVP, EMEACLA AND JAPAC

    2023-03-08 17:57:04 -0500 2023-03-08 M 6,640 $35.20 a 175,515 direct yes -2.2228 7.7338 7.7338 6 -2.2228 2

    LEMERCIER JEAN-LUC M - Officer CVP, EMEACLA AND JAPAC

    2023-03-08 17:57:04 -0500 2023-03-08 S 6,590 $76.95 d 168,875 direct yes -2.2228 7.7338 7.7338 6 -2.2228 2

    ULLEM SCOTT B. - Officer CVP, CHIEF FINANCIAL OFFICER

    2023-02-21 20:57:33 -0500 2023-02-21 F 335 $78.51 d 17,784 direct 2.8503 5.8597 6.6419 5 0.0 1

    ULLEM SCOTT B. - Officer CVP, CHIEF FINANCIAL OFFICER

    2023-02-17 18:34:40 -0500 2023-02-16 A 1,941 a 18,119 direct -0.1588 6.4725 6.4725 6 -0.1588 2

    STONE HEISZ LESLIE - Director

    2023-02-16 18:21:14 -0500 2023-02-16 M 9,671 d 0 direct

    STONE HEISZ LESLIE - Director

    2023-02-16 18:21:14 -0500 2023-02-16 S 9,671 $76.82 d 27,480 direct -3.7702 -1.4903 0.0 1 -3.9231 3

    STONE HEISZ LESLIE - Director

    2023-02-16 18:21:14 -0500 2023-02-16 M 9,671 $35.68 a 37,151 direct -3.7702 -1.4903 0.0 1 -3.9231 3

    WOOD LARRY L - Officer CVP & GRP PRESIDENT TAVR & SSH

    2023-02-17 18:35:10 -0500 2023-02-16 A 3,235 a 205,467 direct -0.1588 6.4725 6.4725 6 -0.1588 2

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-02-15 18:20:44 -0500 2023-02-15 M 4,000 d 4,435 direct

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-02-15 18:20:44 -0500 2023-02-15 S 4,000 $76.01 d 18,911 direct yes 1.5916 -1.3328 1.5916 2 -2.3939 4

    CHOPRA DAVEEN - Officer CVP, TMTT

    2023-02-15 18:20:44 -0500 2023-02-15 M 4,000 $45.28 a 22,911 direct yes 1.5916 -1.3328 1.5916 2 -2.3939 4

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-03-14 20:47:24 -0400 2023-02-15 G 96,405 d 60,948 direct 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO by living trust

    2023-03-14 20:47:24 -0400 2023-02-15 G 96,405 a 3,588,422 indirect 3.0574 -0.0881 3.0574 2 -0.0881 6

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-02-14 19:14:53 -0500 2023-02-14 M 29,375 d 88,125 direct

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-02-14 19:14:53 -0500 2023-02-14 S 3,600 $77.75 d 183,128 direct yes -0.8214 -0.4363 0.7572 3 -3.1956 5

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO by living trust

    2023-02-14 19:14:53 -0500 2023-02-14 G 9,500 a 3,492,017 indirect -0.8214 -0.4363 0.7572 3 -3.1956 5

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-02-14 19:14:53 -0500 2023-02-14 G 9,500 d 173,628 direct -0.8214 -0.4363 0.7572 3 -3.1956 5

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-02-14 19:14:53 -0500 2023-02-14 S 16,275 $76.83 d 157,353 direct yes -0.8214 -0.4363 0.7572 3 -3.1956 5

    MUSSALLEM MICHAEL A - Director - Officer CHAIRMAN & CEO

    2023-02-14 19:14:53 -0500 2023-02-14 M 29,375 $35.20 a 186,728 direct yes -0.8214 -0.4363 0.7572 3 -3.1956 5

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-02-06 20:47:19 -0500 2023-02-06 M 6,725 $35.20 a 69,286 direct yes -2.4488 -4.3103 -0.7871 2.3488 18 -7.1214 23

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-02-06 20:47:19 -0500 2023-02-06 M 6,725 d 13,450 direct

    BOBO DONALD E JR - Officer CVP,STRATEGY/CORP DEVELOPMENT

    2023-02-06 20:47:19 -0500 2023-02-06 S 6,725 $80.75 d 62,561 direct yes -2.4488 -4.3103 -0.7871 2.3488 18 -7.1214 23

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 22:15:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 21:45:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 21:15:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 20:45:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 20:15:04 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 19:45:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 19:15:04 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 18:45:04 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 18:15:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 17:45:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 17:15:03 UTC 4.57 0.25 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 16:45:03 UTC 4.4119 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 16:15:03 UTC 4.4119 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 15:45:03 UTC 4.4119 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 15:15:03 UTC 4.4119 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 14:45:03 UTC 4.1619 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 14:15:03 UTC 4.1619 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 13:45:03 UTC 4.1619 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 13:15:04 UTC 4.1619 0.4081 0
    EDWARDS LIFESCIENCES CORP EW 2023-03-24 12:45:03 UTC 4.1619 0.4081 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    JPMorgan Trust IV- JPMorgan Value Plus Fund EW -227.0 shares, $-49919.57 2019-09-30 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund EW -39.0 shares, $-7356.18 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund EW -6.0 shares, $-1131.72 2020-03-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund EW -182.0 shares, $-15222.48 2021-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund EW -1251.0 shares, $-104633.64 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund EW -2200.0 shares, $-210980.0 2021-05-31 N-PORT
    AGF Investments Trust- AGFIQ Hedged Dividend Income Fund EW -69.0 shares, $-8122.68 2022-03-31 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund EW -106.0 shares, $-7908.66 2022-12-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund EW -664.0 shares, $-49541.04 2022-12-31 N-PORT
    JPMorgan Trust I- JPMorgan U.S. Large Cap Core Plus Fund EW -34024.0 shares, $-2538530.64 2022-12-31 N-PORT
    First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF EW -58320.0 shares, $-4473144.0 2023-01-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Diana Harshbarger republican House Filing 2023-02-24 2023-01-25 SP P $1,001-$15,000
    Hon. Diana Harshbarger republican House Filing 2023-02-24 2023-01-25 P $1,001-$15,000
    Hon. Rohit Khanna democrat House Filing 2022-12-02 2022-11-03 SP P $1,001-$15,000
    Hon. Rohit Khanna democrat House Filing 2022-12-02 2022-11-02 DC P $1,001-$15,000
    Hon. Diana Harshbarger republican House Filing 2022-11-23 2022-10-27 P $1,001-$15,000
    Hon. Diana Harshbarger republican House Filing 2022-11-23 2022-10-27 SP P $1,001-$15,000
    Hon. Diana Harshbarger republican House Filing 2022-11-23 2022-10-27 JT P $1,001-$15,000
    Hon. Diana Harshbarger republican House Filing 2022-11-23 2022-10-27 P $1,001-$15,000

    Elevate your investments